Regen BioPharma Inc (RGBP)

[Skiluc]

Edited. Thats an opinion. Big funding changes everything. Recent events(big ones at that) matter alot more then jibber jabber about funding that ran out 5 years ago. On one project. When we own what 10 different IPs? At least? And a whole lot of action with Koos!

And please, Lets not pretend that the debts of this company were not just clearly addressed in the 8k(suggesting of settlement, and restart of relationship with ChemDiv(which are awesome and that means our IP is too!):

On March 23,2021 Todd S. Caven ( “Caven”) entered into an agreement with Regen BioPharma, Inc. ( “Company”) whereby Caven would assist the Company in obtaining the agreement of the creditors of the Company (“Creditors” or singularly “Creditor”) to settle any and all claims against the Company upon terms acceptable to the Company (“Agreement”).
The term of the Agreement shall be from March 24,2021 to March 24,2022.

So in plain English: they bought themselves a year. And in this funding environment, the progressed IP we have... Koos being funded(paid) and having funded CROs advancing his IP already... Dividend class shares... must i keep going on how running out of funds in 2016 on one project doesnt matter? Only the advanced IP we hold and koos new Patent and all his recebt deals matter.

And there is nothing wrong in 2016. Funding ran out. Then public attack everywhere public and possible took place. Not hard to connect the dots...

I have all the time and patience and understanding to be proven correct.

Cheers to everyone. Happy Easter.